This is the banner text
Mr. Meury is a Senior Operating Adviser at Hildred. He is currently CEO at Incyte, a global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines in oncology and dermatology. Previously, Mr. Meury was the CEO of Anthos Therapeutics, a clinical-stage biopharmaceutical company focused on cardiovascular and metabolic disease, which was acquired by Novartis. He is also the former President and CEO of Karuna Therapeutics, a public neurology-focused company, which was acquired by Bristol Myers Squibb. Before joining Hildred, Mr. Meury served as the Chief Commercial Officer for Allergan from 2015-2020 where he had total P&L responsibility for over 50 products with $16 billion in revenue and over $3 billion in sales and marketing investment.
